Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With Pathogenic Variants.
Authors
Schwarz, NiklasSeiffert, Simone
Pendziwiat, Manuela
Rademacher, Annika Verena
Brünger, Tobias
Hedrich, Ulrike B S
Augustijn, Paul B
Baier, Hartmut
Bayat, Allan
Bisulli, Francesca
Buono, Russell J
Bruria, Ben Zeev
Doyle, Michael G
Guerrini, Renzo
Heimer, Gali
Iacomino, Michele
Kearney, Hugh
Klein, Karl Martin
Kousiappa, Ioanna
Kunz, Wolfram S
Lerche, Holger
Licchetta, Laura
Lohmann, Ebba
Minardi, Raffaella
McDonald, Marie
Montgomery, Sarah
Mulahasanovic, Lejla
Oegema, Renske
Ortal, Barel
Papacostas, Savvas S
Ragona, Francesca
Granata, Tiziana
Reif, Phillip S
Rosenow, Felix
Rothschild, Annick
Scudieri, Paolo
Striano, Pasquale
Tinuper, Paolo
Tanteles, George A
Vetro, Annalisa
Zahnert, Felix
Goldberg, Ethan M
Zara, Federico
Lal, Dennis
May, Patrick
Muhle, Hiltrud
Helbig, Ingo
Weber, Yvonne
Issue Date
2022-03-21Keywords
EpilepsyKCNC2
phenotype
genetic
Metadata
Show full item recordJournal
NeurologyDOI
10.1212/WNL.0000000000200660PubMed ID
35314505Abstract
KCNC2 encodes Kv3.2, a member of the Shaw-related (Kv3) voltage-gated potassium channel subfamily, which is important for sustained high-frequency firing and optimized energy efficiency of action potentials in the brain. The objective of this study was to analyze the clinical phenotype, genetic background, and biophysical function of disease-associated Kv3.2 variants.Item Type
ArticleLanguage
enEISSN
1526-632Xae974a485f413a2113503eed53cd6c53
10.1212/WNL.0000000000200660